IN THIS ISSUE

Editor's Memo
John Marcille
Medication Management
Martin Sipkoff
Studies suggest that the benefits of the medications for mild-to-moderate patients are minimal or nonexistent
Tomorrow's Medicine
Thomas Morrow, MD
Will insurers provide coverage for a new device that takes much of the guesswork out of screening for this deadly skin cancer?
Plan Watch
Frank Diamond
Disease management should be a function of primary care, some industry proponents argue. Did someone say patient-centered medical home?
News and Commentary
News and Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report